HG Infra Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 8:59 pm

Competitors of HG Infra Engineering Ltd

All Competitor Stocks of HG Infra Engineering Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:50 am

Below is a detailed analysis of the quarterly data for HG Infra Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,482.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,361.00 Cr. (Mar 2025) to 1,482.00 Cr., marking an increase of 121.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,223.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,121.00 Cr. (Mar 2025) to 1,223.00 Cr., marking an increase of 102.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 259.00 Cr.. The value appears strong and on an upward trend. It has increased from 239.00 Cr. (Mar 2025) to 259.00 Cr., marking an increase of 20.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 18.00 Cr..
• For Interest, as of Jun 2025, the value is 95.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.00 Cr. (Mar 2025) to 95.00 Cr., marking an increase of 24.00 Cr..
• For Depreciation, as of Jun 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 37.00 Cr. (Mar 2025) to 36.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 132.00 Cr.. The value appears to be declining and may need further review. It has decreased from 151.00 Cr. (Mar 2025) to 132.00 Cr., marking a decrease of 19.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 3.00% (Mar 2025) to 25.00%, marking an increase of 22.00%.
• For Net Profit, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 147.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 48.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 15.16. The value appears to be declining and may need further review. It has decreased from 22.55 (Mar 2025) to 15.16, marking a decrease of 7.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:14 am

Growth

Last Updated: September 5, 2025, 5:45 am

Balance Sheet

Last Updated: August 11, 2025, 2:00 pm

Below is a detailed analysis of the balance sheet data for HG Infra Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 65.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 65.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,884.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,390.00 Cr. (Mar 2024) to 2,884.00 Cr., marking an increase of 494.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,170.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,513.00 Cr. (Mar 2024) to 4,170.00 Cr., marking an increase of 2,657.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,570.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,435.00 Cr. (Mar 2024) to 1,570.00 Cr., marking an increase of 135.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 8,690.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,403.00 Cr. (Mar 2024) to 8,690.00 Cr., marking an increase of 3,287.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 885.00 Cr.. The value appears strong and on an upward trend. It has increased from 742.00 Cr. (Mar 2024) to 885.00 Cr., marking an increase of 143.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,349.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 1,349.00 Cr., marking an increase of 1,335.00 Cr..
• For Investments, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 6,444.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,637.00 Cr. (Mar 2024) to 6,444.00 Cr., marking an increase of 1,807.00 Cr..
• For Total Assets, as of Mar 2025, the value is 8,690.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,403.00 Cr. (Mar 2024) to 8,690.00 Cr., marking an increase of 3,287.00 Cr..

However, the Borrowings (4,170.00 Cr.) are higher than the Reserves (2,884.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for HG Infra Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 77.55. This value is within the healthy range. It has decreased from 82.64 (Mar 24) to 77.55, marking a decrease of 5.09.
• For Diluted EPS (Rs.), as of Mar 25, the value is 77.55. This value is within the healthy range. It has decreased from 82.64 (Mar 24) to 77.55, marking a decrease of 5.09.
• For Cash EPS (Rs.), as of Mar 25, the value is 99.47. This value is within the healthy range. It has decreased from 104.25 (Mar 24) to 99.47, marking a decrease of 4.78.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 452.60. It has increased from 376.71 (Mar 24) to 452.60, marking an increase of 75.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 452.60. It has increased from 376.71 (Mar 24) to 452.60, marking an increase of 75.89.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 775.83. It has decreased from 825.29 (Mar 24) to 775.83, marking a decrease of 49.46.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 164.47. This value is within the healthy range. It has decreased from 165.68 (Mar 24) to 164.47, marking a decrease of 1.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is 142.32. This value is within the healthy range. It has decreased from 144.02 (Mar 24) to 142.32, marking a decrease of 1.70.
• For PBT / Share (Rs.), as of Mar 25, the value is 104.22. This value is within the healthy range. It has decreased from 113.48 (Mar 24) to 104.22, marking a decrease of 9.26.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 77.31. This value is within the healthy range. It has decreased from 82.59 (Mar 24) to 77.31, marking a decrease of 5.28.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 77.56. This value is within the healthy range. It has decreased from 82.64 (Mar 24) to 77.56, marking a decrease of 5.08.
• For PBDIT Margin (%), as of Mar 25, the value is 21.19. This value is within the healthy range. It has increased from 20.07 (Mar 24) to 21.19, marking an increase of 1.12.
• For PBIT Margin (%), as of Mar 25, the value is 18.34. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 18.34, marking an increase of 0.89.
• For PBT Margin (%), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 13.75 (Mar 24) to 13.43, marking a decrease of 0.32.
• For Net Profit Margin (%), as of Mar 25, the value is 9.96. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 9.96, marking a decrease of 0.04.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.99. This value is within the healthy range. It has decreased from 10.01 (Mar 24) to 9.99, marking a decrease of 0.02.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.13. This value is within the healthy range. It has decreased from 21.93 (Mar 24) to 17.13, marking a decrease of 4.80.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.62. This value is within the healthy range. It has decreased from 25.55 (Mar 24) to 14.62, marking a decrease of 10.93.
• For Return On Assets (%), as of Mar 25, the value is 5.76. This value is within the healthy range. It has decreased from 9.91 (Mar 24) to 5.76, marking a decrease of 4.15.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.07. This value exceeds the healthy maximum of 1. It has increased from 0.44 (Mar 24) to 1.07, marking an increase of 0.63.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.39. This value exceeds the healthy maximum of 1. It has increased from 0.61 (Mar 24) to 1.39, marking an increase of 0.78.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.71. It has decreased from 1.04 (Mar 24) to 0.71, marking a decrease of 0.33.
• For Current Ratio (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.58, marking a decrease of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 1.39. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.39, marking a decrease of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.52. This value exceeds the healthy maximum of 8. It has increased from 8.51 (Mar 24) to 13.52, marking an increase of 5.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 20. It has increased from 1.51 (Mar 24) to 1.93, marking an increase of 0.42.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 20. It has increased from 1.19 (Mar 24) to 1.50, marking an increase of 0.31.
• For Earning Retention Ratio (%), as of Mar 25, the value is 98.07. This value exceeds the healthy maximum of 70. It has decreased from 98.49 (Mar 24) to 98.07, marking a decrease of 0.42.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.50. This value exceeds the healthy maximum of 70. It has decreased from 98.81 (Mar 24) to 98.50, marking a decrease of 0.31.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.05. This value is within the healthy range. It has decreased from 4.98 (Mar 24) to 4.05, marking a decrease of 0.93.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.84. This value is below the healthy minimum of 3. It has decreased from 3.40 (Mar 24) to 2.84, marking a decrease of 0.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 10,780.71. It has increased from 7,225.50 (Mar 24) to 10,780.71, marking an increase of 3,555.21.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.34 (Mar 24) to 2.13, marking an increase of 0.79.
• For EV / EBITDA (X), as of Mar 25, the value is 10.06. This value is within the healthy range. It has increased from 6.69 (Mar 24) to 10.06, marking an increase of 3.37.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.36, marking an increase of 0.26.
• For Retention Ratios (%), as of Mar 25, the value is 98.06. This value exceeds the healthy maximum of 70. It has decreased from 98.48 (Mar 24) to 98.06, marking a decrease of 0.42.
• For Price / BV (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has decreased from 2.41 (Mar 24) to 2.33, marking a decrease of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.36, marking an increase of 0.26.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.07, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness